Showing results (21-30 of 126) with videos related to
Sort By:
Pageof 13
Physics in Medicine and Biology|December 20, 2018
Response-to-repeatability of quantitative imaging features for longitudinal response assessmentChristie Lin, Stephanie Harmon, Tyler Bradshaw, et al.Human Vaccines & Immunotherapeutics|August 29, 2024
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancerTommaso P Tonelli, Jens C Eickhoff, Laura E Johnson, et al.Cancers|March 28, 2026
Androgen Receptor Point Mutations: A Mechanism of Therapeutic Resistance and a Framework for Rational Drug DesignAvan Colah, Sára Ferková, Han Zhang, et al.Physics in Medicine and Biology|December 29, 2022
Comparison of automated full-body bone metastases delineation methods and their corresponding prognostic powerBrayden Schott, Amy J Weisman, Timothy G Perk, et al.Urologic Oncology|April 13, 2011
A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancerJeremy Cetnar, George Wilding, Douglas McNeel, et al.Physics in Medicine and Biology|November 21, 2018
A statistically optimized regional thresholding method (SORT) for bone lesion detection in 18F-NaF PET/CT imagingTimothy Perk, Song Chen, Stephanie Harmon, et al.Clinical Genitourinary Cancer|August 15, 2015
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)Michael A Carducci, Judith Manola, Suresh G Nair, et al.Physics in Medicine and Biology|November 21, 2018
Automated classification of benign and malignant lesions in 18F-NaF PET/CT images using machine learningTimothy Perk, Tyler Bradshaw, Song Chen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2015
PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled RamucirumabHaiming Luo, Christopher G England, Stephen A Graves, et al.Oncotarget|June 8, 2018
Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancerDouglas G McNeel, Jens C Eickhoff, Ellen Wargowski, et al.Pageof 13